Vicarious Surgical, a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, announced the pricing of its underwritten public offering of 45,000,000 shares of its Class A common stock (Common Stock) at a price to the public of $1 per share.
In addition, Vicarious Surgical has granted the underwriters a 30-day option to purchase up to an additional 6,750,000 shares of its Common Stock. Before deducting the underwriting discounts and commissions and estimated offering expenses, the Company expects to receive total gross proceeds of approximately $45.0 million, assuming no exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about August 7, 2023, subject to the satisfaction of customary closing conditions.
